125 related articles for article (PubMed ID: 9475335)
21. Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs.
Zaheer-ul-Haq ; Khan W
J Comput Aided Mol Des; 2011 Jan; 25(1):81-101. PubMed ID: 21116684
[TBL] [Abstract][Full Text] [Related]
22. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
23. Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library.
Davenport MP; Quinn CL; Valsasnini P; Sinigaglia F; Hill AV; Bell JI
Immunology; 1996 Aug; 88(4):482-6. PubMed ID: 8881746
[TBL] [Abstract][Full Text] [Related]
24. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
[TBL] [Abstract][Full Text] [Related]
25. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
[TBL] [Abstract][Full Text] [Related]
26. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
27. The relative importance of individual DR binding motif positions as defined by peptide anchor analysis of influenza hemagglutinin peptide 306-318 and human myelin basic protein peptide 152-165 binding to several DR molecules: definition of a common extended DR binding motif.
Posch PE; Hastings AE; Rosen-Bronson S; Richert JR; Hurley CK
Eur J Immunol; 1996 Aug; 26(8):1884-91. PubMed ID: 8765035
[TBL] [Abstract][Full Text] [Related]
28. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR Contacting Residue Orientation can be observed in modified protection-inducing malarial synthetic peptides.
Patarroyo ME; Cifuentes G; Salazar LM; Espejo F; Alba MP; Bermúdez A
Curr Med Chem; 2005; 12(24):2849-65. PubMed ID: 16305475
[TBL] [Abstract][Full Text] [Related]
29. Reshuffling of ancient peptide binding motifs between HLA-DRB multigene family members: old wine served in new skins.
Doxiadis GG; de Groot N; de Groot NG; Doxiadis II; Bontrop RE
Mol Immunol; 2008 May; 45(10):2743-51. PubMed ID: 18395261
[TBL] [Abstract][Full Text] [Related]
30. Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development.
Patarroyo ME; Cifuentes G; Baquero J
Immunogenetics; 2006 Jul; 58(7):598-606. PubMed ID: 16791622
[TBL] [Abstract][Full Text] [Related]
31. Predicting peptide binding to MHC pockets via molecular modeling, implicit solvation, and global optimization.
Schafroth HD; Floudas CA
Proteins; 2004 Feb; 54(3):534-56. PubMed ID: 14748001
[TBL] [Abstract][Full Text] [Related]
32. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice.
Menconi F; Monti MC; Greenberg DA; Oashi T; Osman R; Davies TF; Ban Y; Jacobson EM; Concepcion ES; Li CW; Tomer Y
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14034-9. PubMed ID: 18779568
[TBL] [Abstract][Full Text] [Related]
33. PRBAM: a new tool to analyze the MHC class I and HLA-DR anchor motifs.
Mestre-Ferrer A; Scholz E; Humet-Alsius J; Alvarez I
Immunology; 2019 Feb; 156(2):187-198. PubMed ID: 30408168
[TBL] [Abstract][Full Text] [Related]
34. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
Nepom BS; Nepom GT; Coleman M; Kwok WW
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
[TBL] [Abstract][Full Text] [Related]
36. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
Zhang C; Anderson A; DeLisi C
J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
[TBL] [Abstract][Full Text] [Related]
37. The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding.
Verreck FA; Vermeulen C; Poel AV; Jorritsma P; Amons R; Coligan JE; Drijfhout JW; Koning F
Int Immunol; 1996 Mar; 8(3):397-404. PubMed ID: 8671626
[TBL] [Abstract][Full Text] [Related]
38. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis.
Maier JT; Haug M; Föll JL; Beck H; Kalbacher H; Rammensee HG; Dannecker GE
Immunogenetics; 2002 May; 54(2):67-73. PubMed ID: 12037598
[TBL] [Abstract][Full Text] [Related]
39. HLA-DR polymorphism affects the interaction with CD4.
Fleury S; Thibodeau J; Croteau G; Labrecque N; Aronson HE; Cantin C; Long EO; Sékaly RP
J Exp Med; 1995 Sep; 182(3):733-41. PubMed ID: 7650480
[TBL] [Abstract][Full Text] [Related]
40. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.
Falk K; Rötzschke O; Stevanović S; Jung G; Rammensee HG
Immunogenetics; 1994; 39(4):230-42. PubMed ID: 8119729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
